Skip to main content
Premium Trial:

Request an Annual Quote

Nitto Denko Acquires Avecia Biotechnology

Premium

Japan's Nitto Denko said this week that it has acquired Massachusetts-based nucleic acid manufacturer Avecia Biotechnology.

Terms of the acquisition were not disclosed.

The deal, Nitto Denko said, represents “a significant commitment … to the nucleic acids drug industry.” The company recently forged a collaboration with Quark Pharmaceuticals to develop siRNA-based drugs for fibrotic diseases (GSN 7/15/2010).

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.